EXHIBIT
10.15


 


CONVERTIBLE
PROMISSORY NOTE AMENDMENT


(RENEWAL
OF NOTES)


 


This
CONVERTIBLE PROMISSORY NOTE Amendment (the “Amendment”) is made and
entered into on this 16th day of May, 2016 (the “Effective Date”), by and between Roy Meadows, an
individual, with an address of 207 Jasmine Drive, Longwood, Florida 32779, (the “Holder”), and Lifestyle Medical
Network, Inc., a Nevada corporation, (the “Company”), with an address of 121 South Orange Ave., Suite 1500, Orlando 
Florida  32801and amends the terms and conditions of those two (2) DEMAND CONVERTIBLE PROMISSORY NOTES, dated April 28, 2015
and June 8, 2015 respectively (collectively, the “Notes” and individually, a “Note”), by and between the
Parties (as hereinafter defined) and henceforth is a part thereof. (Holder and the Company may be referred to collectively as
the “Parties”, or individually as a “Party”.)


 


A.     Terms and Conditions for Renewal of the Notes


 


As
of the Effective Date, the Company and Holder hereby agree to the following changes in terms and conditions of the Notes and the
following requirements to be met by the Company as conditions for the Renewal of each Note per each Note’s Section 3. As
a result of the Parties mutual agreement to the following, and the Companies compliance with the following, the Parties hereby
agree to amend each Note whereby each Note shall be renewed for an additional 365 days from its respective Maturity Date, such
that the Note dated April 28, 2015 with a Maturity Date of April 28, 2016, is hereby renewed to April 28, 2017, and the Note dated
June 8, 2015 with a Maturity Date of June 8, 2016, is hereby renewed to June 8, 2017 (The “Renewals”):


 


1.
         Renewal Fees and Outstanding Balances of the Notes. The Parties have agreed that as a condition of the Holder
allowing the Renewals, that the Company shall pay a renewal fee per Note, per each Note’s Section 3, which is 10% of the
outstanding balance of each Note as of its Maturity Date (each a “Renewal Fee”):


 


(a)
The outstanding balance of the Note dated April 28, 2015 on its Maturity Date, April 28, 2016, is $280,000.00 (including accrued
and unpaid interest of $30,000.00), and therefore its Renewal Fee is $28,000.00, resulting in an outstanding balance of $308,000.00
on its Maturity Date, April 28, 2016, per Exhibit A (the “April Note Renewal Fee”).


 


(b)
The outstanding balance of the Note dated June 8, 2015 on its Maturity Date, June 8, 2016, is $279,563.58 (including accrued and
unpaid interest of $29,218.37), and therefore its Renewal Fee is $27,956.36, resulting in an outstanding balance of $307,519.94
on its Maturity Date, June 8, 2016, per Exhibit B (the “June Note Renewal Fee”).


 


(c)
In connection with the Renewals, the Holder has agreed to allow, and the Company has accepted, that each Note’s respective
Renewal Fee shall be added to the outstanding balance of each Note as of its Maturity Date, and that said Renewal Fee per Note
shall contiguously accrue interest under the terms and conditions of the Note until the Note is paid in full, including principal,
interest, fees, and the fulfillment of any and all additional terms and conditions required under each Note.


 


(d)
Each Note until paid in full, including principal, interest, fees, and the fulfillment of any and all additional terms and
conditions under each Note respectively, shall contiguously accrue interest and fees on an ongoing basis per its terms and conditions.


 






    	 	1	 



     


    

 


2.
         Reset of Conversion Price. Specific to each of the Notes,
the second last sentence of Section “5. Conversion of Promissory Note.”, item “(a) Conversion Rights;
Conversion Dates; Conversion Price.”, is hereby amended as follows: “Any amount so converted will be converted
into common stock at a conversion price of $.10 per share (the ‘Conversion Price’).”


 


3.
         Reset of Exercise Price. Specific to each of the Notes,
the third sentence of Section 3 “Renewal.”, item “(c)” of each Note, is hereby amended as follows:
“The Exercise Price of each such issuance of Warrants shall be the same as per Section 8, “Equity Bonus of Common
Stock Purchase Warrant”, wherein said Exercise Price is hereby changed to $0.025 per share.


 


4.
         Renewal Warrant Shares. In addition to the Renewal Fee of
each Note, per Section 3 “Renewal.” of each Note, a Common Stock Purchase Warrant (the “Renewal
Warrant”), in form and content including a “cashless” exercise feature, identical to Exhibit C,
shall be issued to the Holder by the Company at any Exercise Price of $0.025 per share (per “3.” above) within
ten (10) business days of the Effective Date of this Amendment:


 


(a)
For the Renewal of the Note dated April 28, 2015, the quantity of shares issuable under the Renewal Warrant shall be equal to
the Renewal Fee of $28,000.00 per Exhibit A, divided by the Conversion Price (per Section 3 “Renewal.”, item
“(c)”, as amended per item “2.” above) of $.10 per share, rounded up to the next highest share,
or 280,000 shares.


 


(b)
For the Renewal of the Note dated June 8, 2015, the quantity of shares issuable under the Renewal Warrant shall be equal to the
Renewal Fee of $27,956.36, per Exhibit B, divided by the Conversion Price (per Section 3 “Renewal.”, item “(c)”,
as amended per item “2.” above) of $.10 per share, rounded up to the next highest share, or 279,564 shares.


 


Therefore,
the total quantity of shares to be issuable under the single Renewal Warrant for both Notes is 559,564 shares (the “Renewal
Warrant Shares”). The Company agrees to issue said Warrant for the Renewal Warrant Shares within ten (10) business days
of the Effective Date, or not later than May 27, 2016. Failure by the Company to issue said Renewal Warrant within ten (10) business
days of the Effective Date, shall constitute a breach of this Amendment.


 


5.
         Bonus Warrant Shares. The Company acknowledges that per
Section 8 of each of the Notes, “Equity Bonus of Common Stock Purchase Warrant”, that it has not issued the
Common Stock Purchase Warrant as required under this Section for either of the Notes (each a “Bonus Warrant”).
Therefore, the Company agrees that as a condition of the Holder allowing the Renewals, that it will issue the required Bonus
Warrant due per Note, and, per the terms and conditions of Section 8 of each Note, the Company shall issue “two hundred
and fifty thousand (250,000) shares of common stock of the Company expiring five (5) years from its date of its issuance,
exercisable, in whole or in part, on a cashless basis at the sole option of the Holder, at $0.025 per share (the
‘Exercise Price’).” such that a total of five hundred thousand (500,000) shares of common stock of the
Company shall be issued under a single Bonus Warrant to cover the deficiency of the issuance of the Bonus Warrants due under
both of the Notes. The Bonus Warrant shall (a) be dated as of the Effective Date of this Amendment, (b) be in form
and content, including a “cashless” exercise feature, identical to Exhibit C, and (c) be issued to the
Holder within ten (10) business days of the Effective Date of this Amendment. Failure by the Company to issue said Bonus
Warrant within ten (10) business days of the Effective Date, shall constitute a breach of this Amendment.


 


6.
         Total Renewal Warrant Shares and Bonus Warrant Shares.
The total of the Warrant Shares and Bonus Warrant Shares, exercisable over five (5) years at $.025 per share, to be issued by
the Company within ten (10) business days of the Effective Date of this Amendment, or not later than May 27, 2016, is
1,059,564 shares (559,564 Renewal Warrant Shares plus 500,000 Bonus Warrant Shares).


 






    	 	2	 



     


    

 


7.
         Board of Directors Resolution Authorizing Issuance of
Warrant. In addition to the issuance per “6.” above, the Company shall provide to the Holder
simultaneously with the delivery of the Warrant for the 1,059,564 Renewal Warrant Shares and Bonus Warrant Shares, a copy of
its Board of Directors resolution authorizing the Warrant issuance.


 


The
Parties agree and acknowledge that any default or breach of any of the preceding “A. Terms and Conditions for Renewal of
the Notes”, which default or breach is not cured to the satisfaction of the Holder, in his sole judgment and discretion,
within five (5) business days of said default or breach, for which a notice of such default or breach by the Holder to the Company
shall not be required in writing to effect such default or breach which may be declared by the Holder upon the date of its occurrence,
shall render this Amendment null and void immediately as if it were never made. As a result of this Amendment becoming null and
void per the preceding, any outstanding balances of the Notes, including principal, interest, fees, and other charges per the
terms and conditions of the Notes, shall be declared immediately due and payable.


 


B.     General
Provisions


 


1.
         All other terms and conditions specific to each Note, including Section
17. “Governing Law.”, shall remain in full force and effect and remain unchanged.


 


2.
         This Amendment may not be changed or modified except by written
agreement signed by both of the Parties.


 


3.
         This Amendment may be executed in one or more counterparts, each of
which shall be deemed an original and all of which shall constitute one and the same instrument.


 


IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the Effective Date.


 


	HOLDER:
    	 	THE
    COMPANY:
	Roy
    Meadows	 	Lifestyle
    Medical Network Inc. 
	an
    individual	 	a
    Nevada corporation


 


	By:	/s/
    Roy Meadows	 	By:	 /s/ Chris Smith
	 	Roy
    Meadows		 	Christopher
    Smith, CEO


 




    	 	3	 



     


    

 


EXHIBIT
A


 


Lifestyle
Medical Network, Inc. (LMNK)


Roy
Meadows Demand Conv Prom Note, dated 4/28/2015


 


	Date	 	4/29/2015	 	 	4/28/2015	 
	Amount Advanced	 	 	250,000.00	 	 	 	 	 
	Amount Converted	 	 	 	 	 	 	 	 
	Renewal Fee	 	 	 	 	 	 	28,000.00	 
	Balance Outstanding on Date	 	 	250,000.00	 	 	 	308,000.00	 
	Calculation Date	 	 	4/28/2016	 	 	 	4/28/2016	 
	Days Outstanding	 	 	365	 	 	 	366	 
	Interest Rate	 	 	12.00	%	 	 	12.00	%
	Interest Due as of Calculation Date	 	 	30,000.00	 	 	 	-	 
	Total Outstanding	 	 	280,000.00	 	 	 	308,000.00	 



 


EXHIBIT
B


 


Lifestyle
Medical Network, Inc. (LMNK)


Roy
Meadows Demand Conv Prom Note, dated 6/8/2015


 


	Date	 	6/12/2015	 	 	6/19/2015
	 	 	6/8/2016	 
	Amount Advanced	 	 	150,000.00	 	 	 	100,000.00	 	 	 	 	 
	Amount Converted	 	 	 	 	 	 	 	 	 	 	 	 
	Renewal Fee	 	 	 	 	 	 	 	 	 	 	27,956.36	 
	Balance Outstanding on Date	 	 	150,000.00	 	 	 	250,345.21	 	 	 	307,519.94	 
	Calculation Date	 	 	 6/19/2015 	 	 	 	 6/18/2016	 	 	 	 6/8/2016	 
	Days Outstanding	 	 	7	 	 	 	355	 	 	 	0	 
	Interest Rate	 	 	12.00	%	 	 	12.00	%	 	 	12.00	%
	Interest Due as of Calculation Date	 	 	345.21	 	 	 	29,218.37	 	 	 	-	 
	Total Outstanding	 	 	150,345.21	 	 	 	279,563.58	 	 	 	307,519.	94



 






    	 	4	 



     


    

 





EXHIBIT
C


 


Warrant
No. ______


 


THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“THE ACT”),
OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF
EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE,
RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL,
IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND
APPLICABLE STATE LAW IS AVAILABLE.


 


COMMON
STOCK PURCHASE WARRANT


 


LIFESTYLE
MEDICAL NETWORK, INC.


 


(Incorporated
under the laws of the State of Nevada)


 


This
“Common Stock Purchase Warrant”, (“Warrant”), effective May 16, 2016, entitles Roy Meadows,
an individual, residing at 207 Jasmine Lane, Longwood, Florida 32779, or his successors or assigns, (the “Holder”),
for value received, subject to the terms and conditions set forth herein, to purchase from Lifestyle Medical Network, Inc.,
a Nevada corporation (the “Company”), its successors or assigns, in whole or in part, One Million Fifty-Nine Thousand
Five Hundred Sixty-Four (1,059,564) shares of common stock of the Company (the “Common Stock”), which shall be fully
paid and nonassessable securities of the Company (the “Warrant Securities”), upon payment of an exercise price per
share of Common Stock by the Holder, or his successors or assigns, of $0.025 per share, and in accordance to the other terms and
conditions herein.


 


1.      Exercisability.
In accordance with federal and state securities laws and regulation, this Warrant may be exercised in whole or in part,
beginning on the date which is the earlier of (a) six (6) months from the Company being in compliance with the requirements of
being a Reporting Company (as defined as an issuer with a class of securities registered under Section 12 or subject to Section
15(d) of the Securities Exchange Act of 1934, as amended, the “Exchange Act”, which is subject to the periodic and
current reporting requirements of Section 13 or 15(d) of the Securities Exchange Act and is thereinafter referred to as a SEC
“Reporting Company”), or (b) one (1) year from the date hereof if the Company is no longer, or a delinquent Reporting
Company, and up to the date which is five (5) years from the date hereof (the “Exercise Period”), or through May
16, 2021, by presentation and surrender hereof to the Company of a notice of election to purchase duly executed and accompanied
by payment by check or wire transfer of the Exercise Price for such shares to the Company at the Company’s offices, or exercised
in accordance with Section 6 (“Cashless Exercise”) below. Notwithstanding the above, the Holder may not exercise this
Warrant if, at the time of such exercise, the amount of common stock issued upon exercise, when added to other shares of Company
common stock owned by the Holder or which can be acquired by Holder upon exercise or conversion of any other instrument, would
cause the Holder to own more than four and ninety-nine-tenths percent (4.99%) of the Company’s outstanding common stock
(the “Ownership Limitation”) if the Company is a Reporting Company. Such Ownership Limitation shall be increased to
nine and ninety-nine-tenths percent (9.99%) of the Company’s outstanding common stock should the Company file with the SEC
to cease to be a Reporting Company.


 






    	 	5	 



     


    

 


2.      Manner
of Exercise. In case of the purchase of less than all the Warrant Securities, at the request of the Holder the Company
shall cancel this Warrant upon the surrender hereof and shall execute and deliver a new warrant of like tenor for the balance
of the Warrant Securities. Upon the exercise of this Warrant, the issuance of certificates for securities, properties or rights
underlying this Warrant shall be made forthwith without charge to the Holder including, without limitation, any tax that may be
payable in respect of the issuance thereof; provided, however, that the Company shall not be required to pay any tax in respect
of income or capital gain of the Holder.


 


The
Company shall cause the Warrant Securities to be delivered to the Holder within five (5) business days of any Exercise by the
Holder (the “Issuance”), together with a Board of Directors resolution of the Company, and an attorney’s opinion
letter, provided at the sole expense of the Company, addressed to the Company’s transfer agent, verifying the validity of
the Issuance to the Holder.


 


If
and to the extent this Warrant is exercised, in whole or in part, the Holder shall be entitled to receive a certificate or certificates
representing the Warrant Securities so purchased, upon presentation and surrender to the Company of the form of election to purchase
attached hereto duly executed, and accompanied by payment of the purchase price.


 


3.      Adjustment
in Number of Shares.


 


(a)      Adjustment
for Reclassifications. In case at any time or from time to time after the issue date the holders of the Common Stock of the
Company (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received,
or, on or after the record date fixed for the determination of eligible stockholders, shall have become entitled to receive, without
payment therefore, other or additional stock or other securities or property (including cash) by way of stock split, spin-off,
reclassification, combination of shares or similar corporate rearrangement (exclusive of any stock dividend of its or any subsidiary’s
capital stock), then and in each such case the Holder of this Warrant, upon the exercise hereof as provided in Section 1, shall
be entitled to receive the amount of stock and other securities and property which such Holder would hold on the date of such
exercise if on the issue date he had been the holder of record of the number of shares of Common Stock of the Company called for
on the face of this Warrant and had thereafter, during the period from the issue date, to and including the date of such exercise,
retained such shares and/or all other or additional stock and other securities and property receivable by him as aforesaid during
such period, giving effect to all adjustments called for during such period. In the event of any such adjustment, the Exercise
Price shall be adjusted proportionally.


 


(b)      Adjustment
for Reorganization, Consolidation, Merger. In case of any reorganization of the Company (or any other corporation the stock
or other securities of which are at the time receivable on the exercise of this Warrant) after the issue date, or in case, after
such date, the Company (or any such other corporation) shall consolidate with or merge into another corporation or convey all
or substantially all of its assets to another corporation, then and in each such case the Holder of this Warrant, upon the exercise
hereof as provided in Section 1 at any time after the consummation of such reorganization, consolidation, merger or conveyance,
shall be entitled to receive, in lieu of the stock or other securities or property to which such Holder would be entitled had
the Holder exercised this Warrant immediately prior thereto, all subject to further adjustment as provided herein; in each such
case, the terms of this Warrant shall be applicable to the shares of stock or other securities or property of any successor of
the Company as the result of any reorganization, consolidation or merger, receivable upon the exercise of this Warrant after consummation
of any reorganization, consolidation of merger.


 






    	 	6	 



     


    

 


4.      No
Requirement to Exercise. Nothing contained in this Warrant shall be construed as requiring the Holder to exercise this
Warrant prior to or in connection with the effectiveness of a registration statement.


 


5.      No
Stockholder Rights. Unless and until this Warrant is exercised, this Warrant shall not entitle the Holder hereof to any
voting rights or other rights as a stockholder of the Company, or to any other rights whatsoever except the rights herein expressed,
and, no dividends shall be payable or accrue in respect of this Warrant.


 


6.      Cashless
Exercise. In lieu of delivering the Exercise Price in Cash, Holder, at his option, may instruct the Company to retain,
in payment of the Exercise Price, a number of the shares of Common Stock (the “Payment Shares”) equal to the quotient
of the aggregate Exercise Price of the Warrants then being exercised divided by the Market Price of such Payment Shares as of
the date of exercise, and to deduct the number of Payment Shares from the shares of Common Stock to be delivered to such holder.
For purposes of this Warrant, Market Price shall mean the closing bid price of the Company’s common stock on the trading
day immediately before the exercise date. Notwithstanding the above, this Section 6 shall only be applicable provided that the
Company is trading on a recognized exchange on the date of exercise.


 


For
purposes of Rule 144 and sub-section (d)(3)(ii) thereof, it is intended, understood and acknowledged that the Common Stock issued
upon Exercise of this Warrant in a Cashless Exercise transaction shall be deemed to have been acquired at the time this Warrant
was issued. Moreover, it is intended, understood and acknowledged that the holding period for the Common Stock issued upon Exercise
of this Warrant in a Cashless Exercise transaction shall be deemed to have commenced on the date this Warrant was issued.


 


7.      Exchange.
This Warrant is exchangeable upon the surrender hereof by the Holder to the Company for a new warrant of like tenor representing
in the aggregate the right to purchase the number of Warrant Securities purchasable hereunder, each of such new warrants to represent
the right to purchase such number of Warrant Securities as shall be designated by the Holder at the time of such surrender.


 


Upon
receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant,
and, in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it and reimbursement to the company
of all reasonable expenses incidental thereto, and upon surrender and cancellation hereof, if mutilated, the Company will make
and deliver a new warrant of like tenor and amount, in lieu hereof.


 


8.      Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of securities
upon the exercise of this Warrant, nor shall it be required to issue scrip or pay cash in lieu of fractional interests. All fractional
interests shall be eliminated by rounding any fraction up to the nearest whole number of securities, properties or rights receivable
upon exercise of this Warrant.


 






    	 	7	 



     


    

 


9.      Reservation
of Securities. The Company shall at all times reserve and keep available out of its authorized shares of Common Stock
or other securities, solely for the purpose of issuance upon the exercise of this Warrant, such number of shares of Common Stock
or other securities, properties or rights as shall be issuable upon the exercise hereof. The Company covenants and agrees that,
upon exercise of this Warrant and payment of the Principal Value, all shares of Common Stock and other securities issuable upon
such exercise shall be duly and validly issued, fully paid, non-assessable and not subject to the preemptive rights of any stockholder.


 


10.    Notices to Holder. If at any time prior to the expiration of this Warrant or its exercise, any of the following events
shall occur:


 


(a)      The Company shall take a record of the holders of any class of its securities for the purpose of entitling them to receive
a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of current
or retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company; or


 


(b)      The
Company shall offer to all the holders of a class of its securities any additional shares of capital stock of the Company or securities
convertible into or exchangeable for shares of capital stock of the Company, or any option or warrant to subscribe therefor; or


 


(c)      A
dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or merger) or a sale of all
or substantially all of its property, assets and business as an entirety shall be proposed, then, in any one or more said events,
the Company shall give written notice of such event to the Holder at least fifteen (15) days prior to the date fixed as a record
date or the date of closing the transfer books for the determination of the stockholder entitled to such dividend, distribution,
convertible or exchangeable securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation,
winding up or sale. Such notice shall specify such record date or the date of closing the transfer books, as the case may be.


 


11.     Transferability.
This Warrant may be transferred or assigned by the Holder without notice or approval by the Company.


 


12.     Informational
Requirements. The Company will transmit to the Holder such information, documents and reports as are generally distributed
to stockholders of the Company concurrently with the distribution thereof to such stockholders.


 


13.     Notice.
Notices to be given to the Company or the Holder shall be deemed to have been sufficiently given if delivered personally
or sent by overnight courier or messenger, or by facsimile transmission, to the last known address for each party.


 


14.     Consent
to Jurisdiction and Service. The Company consents to the jurisdiction of any court of the State of Florida, and of any
federal court located in Florida, in any action or proceeding arising out of or in connection with this Warrant, wherein said
court shall apply Florida law. The Company waives personal service of any summons, complaint or other process in connection with
any such action or proceeding and agrees that service thereof may be made, by certified mail directed to the Company at the location
provided in Section 13 hereof, or, in the alternative, in any other form or manner permitted by law.


 


15.     Successors.
All the covenants and provisions of this Warrant shall be binding upon and inure to the benefit of the Company, the Holder
and their respective legal representatives, successors and assigns.


 


16.     Attorneys
Fees. In the event the holder hereof shall refer this Warrant to an attorney to enforce the terms hereof, the Company
agrees to pay all the costs and expenses incurred in attempting or effecting collection hereunder, including reasonable attorney's
fees, whether or not suit is instituted.


 






    	 	8	 



     


    

 


17.      Governing Law. THIS WARRANT SHALL BE GOVERNED, CONSTRUED AND INTERPRETED UNDER THE LAWS OF THE STATE OF FLORIDA, WITHOUT
GIVING EFFECT TO THE RULES GOVERNING CONFLICTS OF LAW.


 


18.      Consent to Jurisdiction and Service of Process. The Company consents to the jurisdiction of the courts of the State of
Florida and of any state and federal court located in the County of Seminole, Florida.


 


IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by the signature of its Officer whose name appears below
and to be delivered in Orlando, Florida on this ____ day of May, 2016.


 


	 	LIFESTYLE
    MEDICAL NETWORK, INC.
	 	A
    Nevada corporation
	 	 	 
	 	By:	 
	 		Christopher
    Smith, CEO


 


Acknowledged:


 


	By:
    	 	 
	 	Roy
    Meadows	 


  




    	 	9	 



     


    

 


NOTICE
OF EXERCISE


 


TO:
LIFESTYLE MEDICAL NETWORK, INC.


 


(1)      The
undersigned hereby elects to purchase_____________ shares of the common stock of Lifestyle Medical Network, Inc., a Nevada
corporation, (the “Company”), pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise
price in full, together with all applicable transfer taxes, if any; or


 


The
undersigned hereby elects to purchase_________ shares of the common stock of the Company pursuant to the terms of the
cashless exercise provisions set forth in Section 6 of the attached Warrant, and shall tender payment of all applicable
transfer taxes, if any.


 


(2)      Please
issue a certificate or certificates representing said shares of the Company’s common stock in the name of the undersigned
or in such other name as is specified below:


 


(Name)
______________________________________


 


(Address)
____________________________________


 


(Date)
_______________________________________


 


(Signature)
___________________________________


 


(Print
name) __________________________________




 


 


 



10